Latest news
Search news stories
Enter a keyword to search news.
SAiGENCI recruit recognised with prestigious award
Professor Jenkins has been appointed as the Program Head for the Tumour Inflammation and Immunotherapy Program at the South ÐÓ°ÉÖ±²¥n ImmunoGENomics Cancer Institute (SAiGENCI), which operates within the ÐÓ°ÉÖ±²¥ of Adelaide’s Faculty of Health and Medical Sciences, and is supported by an alliance with the Central Adelaide Local Health Network (CALHN).
[Read more about SAiGENCI recruit recognised with prestigious award]
Towards the future: improving survivorship for children with brain cancer

Brain cancer is the most common solid tumour of childhood and most lethal type of cancer in ÐÓ°ÉÖ±²¥n children.
[Read more about Towards the future: improving survivorship for children with brain cancer]
Unlocking the mysteries of prostate cancer

The SAiGENCI team is creating a comprehensive data repository and applying machine learning to uncover revolutionary insights for prostate cancer treatment and prevention.
[Read more about Unlocking the mysteries of prostate cancer]